• Username (E-mail)
  • Password
Dow 21,141 1.6%  EStoxx50 3,390 2.1%  Nikkei 19,394 1.4%  EUR 1.0551 -0.2% 
Nasdaq 5,905 1.4%  FTSE100 7,383 1.6%  Yen 113.6540 0.7%  Oil 56.4 1.5% 
S&P500 2,398 1.4%  DAX 12,067 2.0%  GBP 1.2292 -0.7%  Gold 1,250 0.1% 

AstraZeneca share [ISIN: GB0009895292]

Realtimequote AstraZeneca PLC in GBP

Exchange Market
46.67
Last
0
Volume
Time 11:29 AM
03/01/2017 11:29:58 AM UTC-0500
activate push

Stock Price AstraZeneca PLC in GBP

Activate push
46.77 GBP 0.33 GBP 0.70 %
Trade Time 4:39 PM Trade Date 3/1/2017
Daily High 47.00 Open 46.55
Daily Low 46.01 Prev. Close 46.44
52-week High 55.05 Volume (Qty.) 2,283,818
52-week Low 36.80 Market Cap (USD) 72.92 B
52-week Perf.
Exchange
The price of 46.77 GBP on the exchange London equals a price of 57.48 USD at the current exchange rate for GBP/USD.

Analyst Opinions for AstraZeneca PLC

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
02/28/17
AstraZeneca Goldman Sachs Group Inc.
02/21/17
AstraZeneca Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02/20/17
AstraZeneca JP Morgan Chase & Co.
02/17/17
AstraZeneca Jefferies & Company Inc.
02/17/17
AstraZeneca Goldman Sachs Group Inc.

Moody's Rating for AstraZeneca PLC

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A3
Rating Update NEW
Date of Rating 5/10/2016
Rating Office Germany

Profile AstraZeneca PLC

Company Profile
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It operates through the following geographical segments: UK; Continental Europe; The Americas; Asia, Africa & Australasia. It produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. It distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. The company was founded on April 6, 1999 and is headquartered in London, the United Kingdom.
pagehit

Add or Edit Instrument

AstraZeneca Chart - 1 Year - LSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: LSE
  • Chart Options

Estimates for AstraZeneca

2016 2017e 2018e
Dividend 2.27 2.19 2.23
Dividend Yield in % 5.02 4.69 4.76
P/E Ratio 12.93 15.67 14.39
EPS 3.49 2.99 3.25

ANALYST DATA FOR AstraZeneca

Sell
Hold
Buy
35
40
45
50
55
60
65
70


AstraZeneca Key Figures

Market Cap (USD) 72.92 B
Free Float in % 95.25
Number of Shares (Mio.) 1,265.23
Cash Flow per Share 2.68
Book Value per Share 9.51
60-Days Volatility 28.73
P/B Ratio 4.74

Base Data AstraZeneca

About the Company AstraZeneca

Country Great Britain

AstraZeneca Historical Prices

02/27/2017
02/27/2017 06:00:00 PM UTC-0500
46.44 2,480,704
02/26/2017
02/26/2017 06:00:00 PM UTC-0500
46.09 1,401,461
02/23/2017
02/23/2017 06:00:00 PM UTC-0500
46.09 1,614,433
02/22/2017
02/22/2017 06:00:00 PM UTC-0500
46.01 2,140,046
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
45.56 2,336,603

AstraZeneca Peer Group

Abbott Laboratories 45.63
1.2%
Alexion Pharmaceuticals 134.15
2.2%
AstraZeneca 46.67
0.2%
Bayer 105.55
1.4%
Celgene 123.84
0.3%
EVOTEC 7.37
1.1%
Gilead Sciences 70.22
-0.4%
Johnson & Johnson 123.81
1.3%
Merck 66.27
0.6%
Merck 104.25
0.9%
Novartis 78.75
0.5%
Pfizer 34.48
1.1%
Roche 246.30
1.2%
Roche 247.90
0.6%
STADA Arzneimittel 57.22
0.2%
Sanofi 82.84
1.9%
Teva Pharmaceutical Industries 34.96
-0.2%
Vertex Pharmaceuticals 90.04
-0.6%